<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39339929</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the Effect of Early-Onset Steroid Treatment in the COVID-19-Positive Pregnant Women on Pregnancy Outcomes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1453</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16091453</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Coronavirus disease 2019 (COVID-19) is the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute respiratory distress and preterm delivery are the two major complications induced by SARS-CoV-2 infection during pregnancy. In the presence of dyspnea, the use of systemic corticosteroids was recommended in pregnant and non-pregnant groups. Our primary aim was to investigate the effect of early-onset steroid treatment on mortality and adverse effects in pregnant women with COVID-19. Our secondary aim was to investigate the effect of steroid treatment on the length of hospital stay and intensive care unit (ICU) stay, and duration of treatment. The study also investigated infection, preterm birth, and ideal body weight (lbw) in newborns.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective study, 253 patients were divided into three groups according to steroid administration. In Group 1 patients (n:112), treatment was started at the time of hospitalization. In Group 2 patients (n:90), treatment was started at least 24 h after hospitalization. Group 3 consisted of patients (n:51) who did not receive steroid treatment. Methylprednisolone (32 mg/day) was given to pregnant patients with a gestational age below 24 weeks or above 34 weeks, and dexametazone (6 mg/day) was given in four doses followed by 32 mg/day methylprednisolone for the others (whose baby was at a gestational age of 24 weeks and above but less than 34 weeks).</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">The hospital stay, ICU stay, and steroid administration time were significantly lower in the Group 1 when compared to the others (<i>p</i> &lt; 0.05). The steroid treatment requirement was 4.4 days in Group 1 and 5.7 days in Group 2 (<i>p</i> &lt; 0.05). While no death was observed in Group 1, one patient died in Group 2 and three patients died in Group 3. There was no difference between the groups in terms of complications, including preterm labor.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">No death was also observed with early-onset treatment. Early-onset treatment may be beneficial for fewer hospitalizations, fewer ICU stays, and less mechanical ventilation requirement in pregnant women with COVID-19. In addition, with early treatment, the total number of steroid administration days was reduced, which is important in terms of reducing the risk of side effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elgormus</LastName><ForeName>Neval</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senyigit</LastName><ForeName>Abdulhalim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okuyan</LastName><ForeName>Omer</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Child Health and Diseases, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozkurt</LastName><ForeName>Fatma</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9807-8257</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydin</LastName><ForeName>Derya Sivri</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uzun</LastName><ForeName>Hafize</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1347-8498</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="Y">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="Y">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="Y">Methylprednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="N">Premature Birth</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">corticosteroids</Keyword><Keyword MajorTopicYN="N">dyspnea</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">preterm labor</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339929</ArticleId><ArticleId IdType="pmc">PMC11437463</ArticleId><ArticleId IdType="doi">10.3390/v16091453</ArticleId><ArticleId IdType="pii">v16091453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allotey J., Fernandez S., Bonet M., Stallings E., Yap M., Kew T., Zhou D., Coomar D., Sheikh J., Lawson H., et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3320</ArticleId><ArticleId IdType="pmc">PMC7459193</ArticleId><ArticleId IdType="pubmed">32873575</ArticleId></ArticleIdList></Reference><Reference><Citation>WAPM (World Association of Perinatal Medicine) Working Group on COVID-19 Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet. Gynecol. 2021;57:232–241. doi: 10.1002/uog.23107. Correction in Ultrasound Obstet. Gynecol. 2021, 58, 496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.23107</ArticleId><ArticleId IdType="pubmed">32926494</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mascio D., Khalil A., Saccone G., Rizzo G., Buca D., Liberati M., Vecchiet J., Nappi L., Scambia G., Berghella V., et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM. 2020;2:100107. doi: 10.1016/j.ajogmf.2020.100107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2020.100107</ArticleId><ArticleId IdType="pmc">PMC7104131</ArticleId><ArticleId IdType="pubmed">32292902</ArticleId></ArticleIdList></Reference><Reference><Citation>Jannasz I., Pruc M., Rahnama-Hezavah M., Targowski T., Olszewski R., Feduniw S., Petryka K., Szarpak L. The Impact of COVID-19 on Carotid-Femoral Pulse Wave Velocity: A Systematic Review and Meta-Analysis. J. Clin. Med. 2023;12:5747. doi: 10.3390/jcm12175747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12175747</ArticleId><ArticleId IdType="pmc">PMC10488425</ArticleId><ArticleId IdType="pubmed">37685813</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., et al. Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med. 2021;384:693–704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Country &amp; Technical Guidance—Coronavirus Disease (COVID-19) World Health Organization; Geneva, Switzerland: 2020.  [(accessed on 24 July 2024)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance.</Citation></Reference><Reference><Citation>Royal College of Obstetricians and Gynaecologits  Coronavirus İnfection in Pregnancy.  [(accessed on 4 March 2021)].  Available online:  https://www.rcog.org.uk/guidance/coronavirus-covid-19-pregnancy-and-women-s-health/</Citation></Reference><Reference><Citation>Magala Ssekandi A., Sserwanja Q., Olal E., Kawuki J., Bashir Adam M. Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence. J. Multidiscip. Healthc. 2021;14:659–663. doi: 10.2147/JMDH.S301255.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S301255</ArticleId><ArticleId IdType="pmc">PMC7981138</ArticleId><ArticleId IdType="pubmed">33758509</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad A.F., Chappell L., Saade G.R., Pacheco L.D. Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19) Obstet. Gynecol. 2020;136:823–826. doi: 10.1097/AOG.0000000000004103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000004103</ArticleId><ArticleId IdType="pubmed">32769659</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts D., Brown J., Medley N., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 2017;3:CD004454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464568</ArticleId><ArticleId IdType="pubmed">28321847</ArticleId></ArticleIdList></Reference><Reference><Citation>The American College of Obstetricians and Gynaecologists  Antenatal Corticosteroid Therapy for Fetal Maturation.  [(accessed on 4 March 2021)].  Available online:  https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/antenatal-corticosteroid-therapy-for-fetalmaturation.</Citation></Reference><Reference><Citation>Pantelis C., Jayaram M., Hannan A.J., Wesselingh R., Nithianantharajah J., Wannan C.M., Syeda W.T., Choy K.C., Zantomio D., Christopoulos A., et al. Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19. Aust. N. Z. J. Psychiatry. 2021;55:750–762. doi: 10.1177/0004867420961472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004867420961472</ArticleId><ArticleId IdType="pmc">PMC8317235</ArticleId><ArticleId IdType="pubmed">32998512</ArticleId></ArticleIdList></Reference><Reference><Citation>La Verde M., Torella M., Riemma G., Narciso G., Iavarone I., Gliubizzi L., Palma M., Morlando M., Colacurci N., De Franciscis P. Incidence of gestational diabetes mellitus before and after the COVİD-19 lockdown: A retrospective cohort study. J. Obstet. Gynaecol. Res. 2022;48:1126–1131. doi: 10.1111/jog.15205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.15205</ArticleId><ArticleId IdType="pmc">PMC9115303</ArticleId><ArticleId IdType="pubmed">35199420</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo C.P., Fontes-Dantas F.L., da Poian A.T., Clarke J.R. SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants. Neuropharmacology. 2021;201:108841. doi: 10.1016/j.neuropharm.2021.108841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2021.108841</ArticleId><ArticleId IdType="pmc">PMC8519783</ArticleId><ArticleId IdType="pubmed">34666076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Sun R., Chen J., Xie Y., Zhang S., Wang X. Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia. Int. J. Gynecol. Obstet. 2020;150:58–63. doi: 10.1002/ijgo.13165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13165</ArticleId><ArticleId IdType="pmc">PMC9087759</ArticleId><ArticleId IdType="pubmed">32270479</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Wang C., Poon L.C. Novel coronavirus infection and pregnancy. Ultrasound Obstet. Gynecol. 2020;55:435–437. doi: 10.1002/uog.22006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.22006</ArticleId><ArticleId IdType="pmc">PMC7169856</ArticleId><ArticleId IdType="pubmed">32134165</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics Practice Bulletin No. 171: Management of Preterm Labor. Obstet. Gynecol. 2016;128:e155–e164. doi: 10.1097/AOG.0000000000001711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000001711</ArticleId><ArticleId IdType="pubmed">27661654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D., Yang H., Cao Y., Cheng W., Duan T., Fan C., Fan S., Feng L., Gao Y., He F., et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int. J. Gynaecol. Obstet. 2020;149:130–136. doi: 10.1002/ijgo.13146. Correction in Int. J. Gynaecol. Obstet. 2020, 150, 136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13146</ArticleId><ArticleId IdType="pmc">PMC9087756</ArticleId><ArticleId IdType="pubmed">32196655</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi L., Makvandi S., Vahedian-Azimi A., Sathyapalan T., Sahebkar A. Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis. J. Pregnancy. 2021;2021:8870129. doi: 10.1155/2021/8870129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8870129</ArticleId><ArticleId IdType="pmc">PMC7938334</ArticleId><ArticleId IdType="pubmed">33728066</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessami K., Homayoon N., Hashemi A., Vafaei H., Kasraeian M., Asadi N. COVID-19 and maternal, fetal and neonatal mortality: A systematic review. J. Matern. Fetal Neonatal Med. 2022;355:2936–2941. doi: 10.1080/14767058.2020.1806817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2020.1806817</ArticleId><ArticleId IdType="pubmed">32799712</ArticleId></ArticleIdList></Reference><Reference><Citation>La Verde M., Riemma G., Torella M., Cianci S., Savoia F., Licciardi F., Scida S., Morlando M., Colacurci N., De Franciscis P. Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics. Int. J. Gynaecol. Obstet. 2021;154:212–219. doi: 10.1002/ijgo.13726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13726</ArticleId><ArticleId IdType="pmc">PMC9087672</ArticleId><ArticleId IdType="pubmed">33930185</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Souza R., Ashraf R., Rowe H., Zipursky J., Clarfield L., Maxwell C., Arzola C., Lapinsky S., Paquette K., Murthy S., et al. Pregnancy and COVID-19: Pharmacologic considerations. Ultrasound Obstet. Gynecol. 2021;57:195–203. doi: 10.1002/uog.23116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.23116</ArticleId><ArticleId IdType="pmc">PMC7537532</ArticleId><ArticleId IdType="pubmed">32959455</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel . Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health (US); Bethesda, MD, USA: 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou A.G., Kotanidou A., Dimopoulou I., Orfanos S.E. Endothelial Damage in Acute Respiratory Distress Syndrome. Int. J. Mol. Sci. 2020;21:8793. doi: 10.3390/ijms21228793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228793</ArticleId><ArticleId IdType="pmc">PMC7699909</ArticleId><ArticleId IdType="pubmed">33233715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F., Klein S.L., Levin E.R. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes. Endocrinology. 2020;161:bqaa127. doi: 10.1210/endocr/bqaa127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa127</ArticleId><ArticleId IdType="pmc">PMC7438701</ArticleId><ArticleId IdType="pubmed">32730568</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri G.U., Bridges L., Shih M.C., Marik P.E., Siemieniuk R.A.C., Kocak M. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42:829–840. doi: 10.1007/s00134-015-4095-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4095-4</ArticleId><ArticleId IdType="pubmed">26508525</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy V.E., Fittock R.J., Zarzycki P.K., Delahunty M.M., Smith R., Clifton V.L. Metabolism of synthetic steroids by the human placenta. Placenta. 2007;28:39–46. doi: 10.1016/j.placenta.2005.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2005.12.010</ArticleId><ArticleId IdType="pubmed">16549198</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J., Ferrando C., Martínez D., Ambrós A., Muñoz T., Soler J.A., Aguilar G., Alba F., González-Higueras E., Conesa L.A., et al. Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir. Med. 2020;8:267–276. doi: 10.1016/S2213-2600(19)30417-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(19)30417-5</ArticleId><ArticleId IdType="pubmed">32043986</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chen F., Zhu S., Li X., Shi W., Dai Z., Hao L., Wang X. Adverse effects of prenatal dexamethasone exposure on fetal development. J. Reprod. Immunol. 2022;151:103619. doi: 10.1016/j.jri.2022.103619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2022.103619</ArticleId><ArticleId IdType="pubmed">35367871</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinisch J.M., Simon N.G., Karow W.G., Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science. 1978;202:436–438. doi: 10.1126/science.705336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.705336</ArticleId><ArticleId IdType="pubmed">705336</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott J.R. Fetal growth retardation associated with maternal administration of immunosuppressive drugs. Am. J. Obstet. Gynecol. 1977;128:668–676. doi: 10.1016/0002-9378(77)90215-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(77)90215-0</ArticleId><ArticleId IdType="pubmed">879225</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine L.G., Barnett E.V., Danovitch G.M., Nissenson A.R., Conolly M.E., Lieb S.M., Barrett C.T. Systemic lupus erythematosus in pregnancy. Ann. Intern. Med. 1981;94:667–677. doi: 10.7326/0003-4819-94-5-667.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-94-5-667</ArticleId><ArticleId IdType="pubmed">7235400</ArticleId></ArticleIdList></Reference><Reference><Citation>Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50:515–525. doi: 10.1542/peds.50.4.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.50.4.515</ArticleId><ArticleId IdType="pubmed">4561295</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabó I., Csaba I., Novák P., Drozgyik I. Single-dose glucocorticoid for prevention of respiratory distress syndrome. Lancet. 1977;2:243. doi: 10.1016/S0140-6736(77)92854-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(77)92854-9</ArticleId><ArticleId IdType="pubmed">69846</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Oxford  The Recovery Trial.  [(accessed on 4 March 2021)].  Available online:  https://www.recoverytrial.net/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>